Mayur Ian Somaiya, CFO: NewAmsterdam Pharma NAMS Planned sale · Filed 01/20

Trade details

Type: Planned sale notice
Stock: NewAmsterdam Pharma NAMS
Person: Mayur Ian SomaiyaCFO
Planned sale date: 26/01/20
Filed: 26/01/20

0.2% of shares outstanding to be sold

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Mayur Ian Somaiya's recent trades

Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.3M
39,712 sh
$1.3M
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$823.4K
24,362 sh
$823.4K
Filed 01/22
Traded 01/21
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$634.8K
19,604 sh
$634.8K
Filed 01/22
Traded 01/20
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$512.8K
15,422 sh
$512.8K
Filed 01/22
Traded 01/21
Mayur Ian SomaiyaCFO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$27.6K
900 sh
$27.6K
Filed 01/22
Traded 01/20

Mayur Ian Somaiya, CFO — plans to sell 200,000 sh of NewAmsterdam Pharma NAMS · $6.3M · around 01/20 · 10b5-1 plan | Whalegun